Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen. [electronic resource]
Producer: 20110325Description: 2391-5 p. digitalISSN:- 1473-5571
- Antiretroviral Therapy, Highly Active
- DNA, Circular -- drug effects
- DNA, Viral -- drug effects
- Female
- HIV Infections -- drug therapy
- HIV Long Terminal Repeat -- drug effects
- HIV-1 -- drug effects
- Humans
- Male
- Pyrrolidinones -- administration & dosage
- Raltegravir Potassium
- Sequence Analysis, DNA
- Viral Load
- Viremia
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.